Classification of chronic kidney disease | Medibuddy
24th June 2023

Classification of chronic kidney disease

Chronic kidney disease (CKD) is defined as a persistent reduction in renal function (for greater than three months); this may be progressive in nature and have consequences for patient health. Classification of CKD is based on glomerular filtration rate (GFR), amount of albuminuria and underlying cause.

GFR categories

Stage GFR (ml/min/1.73m²) Terminology and interventions
G1 ≥90 – considered CKD if accompanied by urinary or imaging markers suggestive of kidney damage Normal or high
G2 60-89 – considered CKD if accompanied by urinary or imaging markers suggestive of kidney damage Mildly reduced
G3a 45-59 Mildly to moderately reduced
G3b 30-44 Moderately to severely reduced
G4 15-29 Severely reduced – likely to need treatment of CKD complications and preparation for renal replacement therapy (RRT) if appropriate
G5 ≤14 Renal failure – consider commencing RRT if appropriate

Table 1: Staging of CKD based on GFR, adapted from the KDIGO 2012 Clinical Practice Guideline for the ‘Evaluation and Management of Chronic Kidney Disease’ and the NICE guideline on ‘Chronic Kidney Disease: Assessment and Management’.

Albuminuria categories

Stage Albumin-to-creatinine ratio (mg/mmol) Terminology
A1 <3 Normal to mildly increased
A2 3-30 Moderately increased
A3 >30 Severely increased – note this category includes the nephrotic range (usually >200mg/mmol)

Table 2: Staging of CKD based on albuminuria, adapted from the KDIGO 2012 Clinical Practice Guideline for the ‘Evaluation and Management of Chronic Kidney Disease’ and the NICE guideline on ‘Chronic Kidney Disease: Assessment and Management’

It is important to note factors that may influence the interpretation of the measurements above, for example, those of particularly high muscle mass or lower than expected muscle mass (e.g. amputees, muscle wasting disorders). It is normal for GFR to gradually decline with increasing age without a patient necessarily having CKD. There are also a number of drugs that cause a rise in plasma creatinine levels due to reduced tubular secretion (e.g. cimetidine, trimethoprim); this will result in a false reduction in calculated GFR.

There are a number of formulae available to calculate estimated GFR (eGFR); the MDRD (Modification of Diet in Renal Disease) was developed in 1999 and previously widely used, however more recent guidance suggests the use of the CKD-EPI equation (Chronic Kidney Disease Epidemiology Collaboration), the first version of which was developed in 2009. The main four variables used in both original equations are serum creatinine, age, sex, and race. The CKD-EPI equation is less biased, especially at higher GFRs, and its latest iteration (2021) does not include race.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.